Category 1: Condition (n = 13 barriers)
|
|
Condition
|
Cognitive limitations
|
A decline in cognitive capabilities, such as reasoning and problem solving, could negatively affect VR use
|
6
|
[35], [36], [46]–[49]
|
|
General decline
|
A decline in functional capabilities, such as mobility or communication, could negatively affect VR use
|
4
|
[36], [46]–[48]
|
|
Distress
|
VR use could induce distress and anxiety
|
4
|
[35], [48]–[50]
|
|
Fatigue
|
Extreme fatigue in patients could negatively affect VR experience
|
1
|
[35]
|
|
Dissociation
|
Experienced disconnection from themselves and the world could negatively affect VR experience
|
1
|
[35]
|
|
Highly medicated
|
Effects of medication use could negatively affect VR use and experience
|
1
|
[49]
|
Physical
|
Cybersickness
|
Motion- or cybersickness experienced while using VR
|
4
|
[10], [35], [49], [51]
|
limitations
|
Issues with vision/hearing
|
Limited vision or hearing abilities could negatively affect VR use
|
3
|
[36], [46], [49]
|
|
Epilepsy
|
VR use could trigger a seizure in patients with photosensitive epilepsy
|
2
|
[51], [52]
|
|
Poor hand dexterity
|
Limited ability moving fingers and hands limits the use of VR controllers
|
1
|
[46]
|
|
Wheelchair users
|
The use of a wheelchair can negatively influence movement in VR
|
1
|
[33]
|
Socio-demographics
|
Reluctance due to old age
|
Elderly can be less technology-aware and uncomfortable to use VR
|
7
|
[35], [38], [47], [48], [53]–[55]
|
|
Language barriers
|
Language can form a barrier when software is in another language
|
1
|
[47], [52]
|
Category 2: Technology (n = 11 barriers)
|
|
Technical functionality
|
Technical issues
|
Technical malfunctioning of VR hardware
|
9
|
[10], [33], [37], [50], [52], [56]–[59]
|
|
Lack of client safety
|
Lack of client safety due to unforeseen movement of patient in the treatment room while using VR
|
6
|
[10], [35], [38], [39], [60], [61]
|
|
No reliable Wi-Fi
|
No reliable network connection which is necessary to use VR
|
4
|
[37], [53], [54], [57]
|
|
Infection control issues
|
Difficult to control contaminations when using VR with multiple patients
|
3
|
[48], [49], [59]
|
|
Data privacy and security
|
Lack of data privacy and security when using patient data in VR
|
2
|
[38], [58]
|
|
System not charged
|
Battery of VR system is not charged and VR cannot be used
|
1
|
[57]
|
Usability
|
Lack of patient comfort
|
The use of VR headset and headphones could be uncomfortable
|
4
|
[35], [38], [59], [62]
|
|
Usability issues
|
Issues with the usability and user-friendliness of VR
|
3
|
[35], [39], [61]
|
|
Additional effort
|
The use of VR adds additional steps for caregivers during treatment
|
2
|
[10], [57]
|
Effect of VR on treatment
|
Isolation from contact
|
The VR headset can isolate patients from human contact
|
6
|
[50], [51], [53]–[55], [62]
|
|
Lack of realism
|
Lack of realism and immersion experienced by patients in VR
|
4
|
[10], [50], [51], [63]
|
Category 3: Value proposition (n = 8 barriers)
|
|
Influencing treatment
|
Lack of personalization
|
Lack of personalization to treatment goals and patients’ needs
|
6
|
[10], [38], [57], [58], [64], [65]
|
|
Distract from goals
|
The fun and gamification aspects of VR could distract from treatment goals
|
1
|
[37]
|
|
Disinterest therapeutic activities
|
The preference for VR treatment could cause disinterest in other therapeutic activities
|
1
|
[37]
|
|
No translation into real-world improvement
|
Treatment improvements in VR do not directly translate into real-world improvements outside of the treatment room
|
1
|
[58]
|
|
Avoid in-vivo exposure
|
The use of VR can be a way to avoid in-vivo exposure
|
1
|
[50]
|
|
Biased attention in group therapy
|
When VR is used in group therapy, the attention of the caregiver is focused on one patient and not on the other participants
|
1
|
[57]
|
Practical resources
|
Financial costs
|
Costs of purchasing and time for maintaining VR
|
9
|
[35], [38], [39], [48], [51]–[54], [58]
|
|
Time for maintaining
|
Lack of time for the maintenance and updating of VR software
|
3
|
[10], [38], [52]
|
Category 4: Adopter system (n = 18 barriers)
|
|
Factors that Influence
|
Lack of research
|
Perceived lack of research and evidence on the added value of VR
|
10
|
[10], [33], [35], [38], [47]–[49], [51], [54], [64]
|
Opinion towards VR
|
Lack of experience
|
Perceived lack of experience in working with VR
|
7
|
[33], [36], [38], [50], [53], [54], [56]
|
- caregivers
|
Lack of suitable patients
|
Perceived lack of appropriate patients that can be referred to VR treatment or perceived lack of support in referring patients
|
3
|
[10], [33], [34]
|
|
Lack of support
|
Perceived lack of support from management in using VR
|
3
|
[23], [33], [34]
|
|
Dissatisfaction with VR
|
Not satisfied with the use of VR hardware or software
|
2
|
[48], [56]
|
|
No interest in VR use
|
Not interested in using VR technology in treatment
|
1
|
[64]
|
|
Negative patient response
|
Expected negative patient response towards VR
|
1
|
[54]
|
|
Resistance to new treatment
|
A general resistance towards new therapeutic approaches
|
1
|
[35]
|
Factors that influence
|
Low patient motivation
|
Patient motivation is low for VR treatment
|
5
|
[10], [33], [36], [58], [64]
|
opinion towards VR
|
Stress inducing
|
The new aspects of VR technology could be stress inducing because patients are exposed to a new form of treatment and new reality
|
2
|
[36], [55]
|
- patients
|
Disorientation during VR
|
Patient could experience disorientation when present in VR scenario
|
1
|
[59]
|
|
Mistrust in new treatment
|
Patient mistrust in new or experimental treatment options
|
1
|
[38]
|
|
No support caregiver
|
Patient does not feel supported in VR use by caregiver
|
1
|
[57]
|
Integrating VR in routines
|
Difficulty combining VR with existing treatment
|
Perceived difficulty combining VR with existing treatments and integrating VR in existing protocols
|
2
|
[37], [46]
|
Knowledge and skills of
|
Lack of time to learn and use VR
|
Lack of perceived time and opportunities to learn how to use VR and integrate VR in treatment
|
8
|
[10], [37], [48], [52]–[54], [57], [64]
|
caregivers
|
Lack of knowledge/skills
|
Lack of knowledge and skills to feel confident using VR
|
5
|
[35], [38], [39], [54], [59]
|
|
Difficulty explaining VR
|
Difficulty explaining the VR system to patients during treatment
|
2
|
[33], [47]
|
|
Difficult to learn VR
|
Difficult to learn how to use VR in treatment with patients
|
1
|
[50]
|
Category 5: Organization (n = 13 barriers)
|
|
Readiness to innovate
|
Other goals taking priority
|
Other goals that do not focus on VR taking priority within the organizational policy
|
1
|
[33]
|
|
Negative culture towards innovation
|
Negative organizational culture towards innovation and new technology
|
1
|
[38]
|
Introducing VR to caregivers
|
No opportunity to try VR
|
Not giving an opportunity to caregivers to try out VR for themselves
|
8
|
[10], [35], [37], [47], [48], [55], [57], [60]
|
|
Lack of education
|
Not organizing enough educational opportunities to learn how to use VR
|
2
|
[10], [47]
|
|
Lack of training courses
|
Not offering enough standardized training courses to caregivers
|
2
|
[[48], [51]
|
Providing support
|
Lack of time to learn VR
|
Not making enough time available for caregivers to learn how to use VR
|
13
|
[10], [33], [37]–[39], [47], [48], [52]–[54], [57], [64], [65]
|
for caregivers
|
Lack of technical support
|
Not offering technical support to help set up the VR system or help fix hardware or software malfunctions
|
12
|
[10], [33]–[35], [38], [39], [48], [52]–[54], [57], [64]
|
|
Lack of rooms
|
Not having enough rooms available for VR treatment
|
8
|
[10], [36]–[38], [47], [48], [57], [64]
|
|
Insufficient VR systems
|
Not having enough VR systems available for VR treatment
|
3
|
[10], [36], [48]
|
|
No official channels to report performance issues
|
Not creating official channels to report performance issues experienced during VR treatment
|
1
|
[57]
|
Integrating VR in workflow
|
Lack of guidelines on patient suitability
|
Lack of guidelines on suitability of patients and medical indication for VR treatment
|
3
|
[35], [38], [57]
|
Providing conditions for
|
Lack of treatment protocols
|
Lack of validated treatment protocols on how to use VR in treatment
|
2
|
[51], [52]
|
use
|
Integration of VR
|
Not integrating VR in existing workflows and traditional treatment
|
1
|
[38]
|
Category 6: Wider system (n = 3 barriers)
|
|
Societal development
|
Not innovation minded
|
Opinion leaders are not innovation-minded and do not support VR
|
2
|
[38], [54]
|
|
Focus on well-being over treatment for specific conditions
|
Health industry’s focus on creating VR for general wellbeing over developing VR treatments for specific conditions
|
1
|
[38]
|
Regulatory/legal issues
|
Ethical or legal concerns
|
Ethical or legal concerns around the use of VR in treatment, such as cybersecurity, privacy and regulations
|
1
|
[58]
|
Category 7: Embedding and adoption over time (n = 3 barriers)
|
|
Challenge to scale up
|
Lack of insurance reimbursement
|
Lack of insurance reimbursement to compensate costs of VR use
|
2
|
[38], [39]
|
|
Sustainability
|
VR use is not sustainable over a longer period of time, because risk of hardware quickly becoming obsolete
|
2
|
[51], [65]
|
|
Lack of technical support
|
Lack of technical support to maintain hardware limits upscale of VR use
|
1
|
[52]
|